An Interest In:
Web News this Week
- April 1, 2024
- March 31, 2024
- March 30, 2024
- March 29, 2024
- March 28, 2024
- March 27, 2024
- March 26, 2024
Some of Our Sources
- Techcrunch
- Web Designer Wall
- Team Treehouse
- Abduzeedo
- TutsPlus - Design
- Web Design Ledger
- Reencoded
- Stylized Web
- Design Modo
- The Verge
Help Webnuz
Referal links:
April 24, 2020 02:48 pm
Original Link: http://rss.slashdot.org/~r/Slashdot/slashdot/~3/SVVosdTg7Ao/drugmaker-tripled-the-price-of-a-pill-as-it-pursued-coronavirus-use
Drugmaker Tripled the Price of a Pill as it Pursued Coronavirus Use
This month, Jaguar Health more than tripled the price of its lone FDA-approved drug, right after asking the federal government to expand the use of its drug to coronavirus patients. AmiMoJo shares a report: Jaguar Health drastically raised the price of a drug during the height of the pandemic, but executives argued the move was needed to stave off the company's collapse. Going into this year, the list price of a 60-pill bottle of Mytesi -- an antidiarrheal medication specifically for people with HIV/AIDS who are on antiretroviral drugs -- was $668.52. On April 9, Jaguar Health raised the price to $2,206.52, according to pricing data from Elsevier's Gold Standard Drug Database. On March 21, Jaguar Health asked the FDA to authorize emergency use of Mytesi for COVID-19 patients who were experiencing any diarrhea or "diarrhea associated with certain antiviral treatments" including remdesivir, among others.Read more of this story at Slashdot.
Original Link: http://rss.slashdot.org/~r/Slashdot/slashdot/~3/SVVosdTg7Ao/drugmaker-tripled-the-price-of-a-pill-as-it-pursued-coronavirus-use
Share this article:
Tweet
View Full Article
Slashdot
Slashdot was originally created in September of 1997 by Rob "CmdrTaco" Malda. Today it is owned by Geeknet, Inc..More About this Source Visit Slashdot